PBIO Financial Facts
Net loss applicable to common shareholders: -945.21KOperating loss: -451.81K
See Full Income Statement
Warrants to acquire preferred stock and common stock: 5.68M
Prepaid expenses and other current assets: 179.95K
See Full Balance Sheet
Pressure BioSciences, Inc. (PBIO) Earnings
|
Expand Research on PBIO
| Next EPS Date | 5/14/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/16/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/15/23 | Q323 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/22/23  |
Q323 | -$0.29 | N/A | N/A | $410K | N/A | N/A |  | | Details | |
| 8/17/23 | Q223 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/22/23 | Q223 | -$0.57 | N/A | N/A | $510K | N/A | N/A | | | Details | |
| 4/4/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 4/18/23 | Q123 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
